Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122999304 | 12299930 | 4 | F | 20160326 | 20160817 | 20160425 | 20160819 | EXP | JP-OTSUKA-2016_008874 | OTSUKA | 48.00 | YR | M | Y | 48.00000 | KG | 20160819 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122999304 | 12299930 | 1 | PS | Aripiprazole (Dual Chamber) | ARIPIPRAZOLE | 1 | Intramuscular | 400 MG, QM | 151.723999 | MG | 202971 | 400 | MG | SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE | /month | ||||
122999304 | 12299930 | 2 | SS | Aripiprazole (Dual Chamber) | ARIPIPRAZOLE | 1 | Intramuscular | 400 MG, QM, BUTTOCKS | 151.723999 | MG | 202971 | 400 | MG | SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE | /month | ||||
122999304 | 12299930 | 3 | SS | HALOPERIDOL. | HALOPERIDOL | 1 | Oral | 2 MG, QD | 0 | 2 | MG | QD | |||||||
122999304 | 12299930 | 4 | SS | HALOPERIDOL. | HALOPERIDOL | 1 | Oral | 3 MG, QD | 0 | 3 | MG | QD | |||||||
122999304 | 12299930 | 5 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | 2 ML, QD | 0 | 2 | ML | QD | |||||||
122999304 | 12299930 | 6 | C | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | UNK | 0 | ORODISPERSIBLE TABLET | |||||||||
122999304 | 12299930 | 7 | C | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 24 MG, QD | 0 | 24 | MG | TABLET | QD | ||||||
122999304 | 12299930 | 8 | C | MEILAX | ETHYL LOFLAZEPATE | 1 | Oral | 2 MG, QD | 0 | 2 | MG | QD | |||||||
122999304 | 12299930 | 9 | C | DORAL | QUAZEPAM | 1 | Oral | 15 MG, QD | 0 | 15 | MG | QD | |||||||
122999304 | 12299930 | 10 | C | FLUNITRAZEPAM | FLUNITRAZEPAM | 1 | Oral | 2 MG, QD | 0 | 2 | MG | QD | |||||||
122999304 | 12299930 | 11 | C | SELENICA-R | VALPROATE SODIUM | 1 | Oral | 1.5 G, QD | 0 | 1.5 | G | GRANULES | QD | ||||||
122999304 | 12299930 | 12 | C | CERCINE | DIAZEPAM | 1 | Oral | 0.25 G, QD | 0 | .25 | G | QD | |||||||
122999304 | 12299930 | 13 | C | BENZALIN | NITRAZEPAM | 1 | Oral | 0.25 G, QD | 0 | .25 | G | ORAL POWDER | QD | ||||||
122999304 | 12299930 | 14 | C | ISOMYTAL | AMOBARBITAL SODIUM | 1 | Oral | 0.25 G, QD | 0 | .25 | G | QD | |||||||
122999304 | 12299930 | 15 | C | PANTOSIN | PANTETHINE | 1 | Oral | 1200 MG, QD | 0 | 1200 | MG | QD | |||||||
122999304 | 12299930 | 16 | C | SENNOSIDE A+B | SENNOSIDES A AND B | 1 | Oral | 24 MG, QD | 0 | 24 | MG | QD | |||||||
122999304 | 12299930 | 17 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Oral | 1000 MG, QD | 0 | 1000 | MG | QD | |||||||
122999304 | 12299930 | 18 | C | CHALDOL | 2 | Oral | 2 MG, QD | 0 | 2 | MG | ORAL SOLUTION | QD | |||||||
122999304 | 12299930 | 19 | C | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
122999304 | 12299930 | 20 | C | XYZAL | LEVOCETIRIZINE DIHYDROCHLORIDE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122999304 | 12299930 | 1 | Schizophrenia |
122999304 | 12299930 | 3 | Schizophrenia |
122999304 | 12299930 | 5 | Schizophrenia |
122999304 | 12299930 | 6 | Product used for unknown indication |
122999304 | 12299930 | 7 | Schizophrenia |
122999304 | 12299930 | 8 | Schizophrenia |
122999304 | 12299930 | 9 | Schizophrenia |
122999304 | 12299930 | 10 | Schizophrenia |
122999304 | 12299930 | 11 | Schizophrenia |
122999304 | 12299930 | 12 | Schizophrenia |
122999304 | 12299930 | 13 | Schizophrenia |
122999304 | 12299930 | 14 | Schizophrenia |
122999304 | 12299930 | 15 | Product used for unknown indication |
122999304 | 12299930 | 16 | Product used for unknown indication |
122999304 | 12299930 | 17 | Product used for unknown indication |
122999304 | 12299930 | 18 | Product used for unknown indication |
122999304 | 12299930 | 19 | Product used for unknown indication |
122999304 | 12299930 | 20 | Prophylaxis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122999304 | 12299930 | DS |
122999304 | 12299930 | OT |
122999304 | 12299930 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122999304 | 12299930 | Abnormal behaviour | |
122999304 | 12299930 | Aggression | |
122999304 | 12299930 | Dysbacteriosis | |
122999304 | 12299930 | Escherichia infection | |
122999304 | 12299930 | Face oedema | |
122999304 | 12299930 | Hypothermia | |
122999304 | 12299930 | Immunodeficiency | |
122999304 | 12299930 | Intestinal obstruction | |
122999304 | 12299930 | Psychiatric symptom | |
122999304 | 12299930 | Respiratory failure | |
122999304 | 12299930 | Stupor |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122999304 | 12299930 | 1 | 20160316 | 0 | ||
122999304 | 12299930 | 2 | 20160413 | 0 | ||
122999304 | 12299930 | 3 | 20160412 | 20160416 | 0 | |
122999304 | 12299930 | 4 | 20160417 | 20160419 | 0 | |
122999304 | 12299930 | 5 | 2016 | 20160419 | 0 | |
122999304 | 12299930 | 6 | 20160108 | 0 | ||
122999304 | 12299930 | 7 | 20160330 | 0 | ||
122999304 | 12299930 | 8 | 20160419 | 0 | ||
122999304 | 12299930 | 9 | 20160419 | 0 | ||
122999304 | 12299930 | 10 | 20160419 | 0 | ||
122999304 | 12299930 | 11 | 20160419 | 0 | ||
122999304 | 12299930 | 12 | 20160419 | 0 | ||
122999304 | 12299930 | 13 | 20160419 | 0 | ||
122999304 | 12299930 | 14 | 20160419 | 0 | ||
122999304 | 12299930 | 15 | 20160419 | 0 | ||
122999304 | 12299930 | 16 | 20160419 | 0 | ||
122999304 | 12299930 | 17 | 20160419 | 0 | ||
122999304 | 12299930 | 18 | 20160419 | 0 | ||
122999304 | 12299930 | 19 | 20160419 | 0 | ||
122999304 | 12299930 | 20 | 20160419 | 0 |